$SBRA
Sabra Health Care REIT, Inc.

2022 Q1 Form 10-Q Financial Statement

#000149229822000020 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $163.1M $152.4M
YoY Change 7.05% 2.02%
Cost Of Revenue $33.10M $28.60M
YoY Change 15.75% 5.93%
Gross Profit $130.0M $123.7M
YoY Change 5.09% 1.06%
Gross Profit Margin 79.7% 81.19%
Selling, General & Admin $10.87M $11.00M
YoY Change -1.17% 18.28%
% of Gross Profit 8.36% 8.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $45.26M $44.38M
YoY Change 1.99% 0.47%
% of Gross Profit 34.81% 35.87%
Operating Expenses $61.14M $60.60M
YoY Change 0.89% 3.95%
Operating Profit $68.86M $63.10M
YoY Change 9.13% -1.56%
Interest Expense -$27.77M -$29.00M
YoY Change -4.23% 0.35%
% of Operating Profit -40.33% -45.96%
Other Income/Expense, Net -$203.0K $653.0K
YoY Change -131.09% -68.02%
Pretax Income $43.69M $39.16M
YoY Change 11.57% -1.93%
Income Tax $284.0K $700.0K
% Of Pretax Income 0.65% 1.79%
Net Earnings $40.60M $33.45M
YoY Change 21.39% -4.98%
Net Earnings / Revenue 24.89% 21.95%
Basic Earnings Per Share $0.18 $0.16
Diluted Earnings Per Share $0.18 $0.16
COMMON SHARES
Basic Shares Outstanding 230.9M shares 211.5M shares
Diluted Shares Outstanding 231.6M shares 212.6M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.84M $24.90M
YoY Change -0.26% -53.97%
Cash & Equivalents $24.84M $24.88M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $180.6M $213.4M
YoY Change -15.37% -1.16%
LONG-TERM ASSETS
Property, Plant & Equipment $5.156B $5.279B
YoY Change -2.34% -1.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $93.88M $283.8M
YoY Change -66.92% -8.98%
Other Assets $4.443M $4.600M
YoY Change -3.41% -45.24%
Total Long-Term Assets $5.704B $5.750B
YoY Change -0.8% -2.14%
TOTAL ASSETS
Total Short-Term Assets $180.6M $213.4M
Total Long-Term Assets $5.704B $5.750B
Total Assets $5.885B $5.964B
YoY Change -1.32% -2.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $92.90M $105.9M
YoY Change -12.28% -5.87%
Accrued Expenses $25.40M $17.60M
YoY Change 44.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $118.3M $123.5M
YoY Change -4.21% 9.78%
LONG-TERM LIABILITIES
Long-Term Debt $2.358B $2.282B
YoY Change 3.33% -7.97%
Other Long-Term Liabilities $47.58M $55.40M
YoY Change -14.11% -47.34%
Total Long-Term Liabilities $2.405B $2.337B
YoY Change 2.91% -9.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $118.3M $123.5M
Total Long-Term Liabilities $2.405B $2.337B
Total Liabilities $2.523B $2.460B
YoY Change 2.56% -8.77%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $2.310M $2.159M
YoY Change 6.99% 5.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.362B $3.503B
YoY Change
Total Liabilities & Shareholders Equity $5.885B $5.964B
YoY Change -1.32% -2.11%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $40.60M $33.45M
YoY Change 21.39% -4.98%
Depreciation, Depletion And Amortization $45.26M $44.38M
YoY Change 1.99% 0.47%
Cash From Operating Activities $63.11M $68.53M
YoY Change -7.9% -8.4%
INVESTING ACTIVITIES
Capital Expenditures -$20.57M -$28.70M
YoY Change -28.32% -57.36%
Acquisitions
YoY Change
Other Investing Activities -$16.67M -$6.700M
YoY Change 148.79% 157.69%
Cash From Investing Activities -$37.24M -$35.36M
YoY Change 5.33% -49.36%
FINANCING ACTIVITIES
Cash Dividend Paid $69.28M $63.22M
YoY Change 9.58% -31.57%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$112.5M -$69.28M
YoY Change 62.42% -874.21%
NET CHANGE
Cash From Operating Activities $63.11M $68.53M
Cash From Investing Activities -$37.24M -$35.36M
Cash From Financing Activities -$112.5M -$69.28M
Net Change In Cash -$86.65M -$36.10M
YoY Change 140.01% -358.92%
FREE CASH FLOW
Cash From Operating Activities $63.11M $68.53M
Capital Expenditures -$20.57M -$28.70M
Free Cash Flow $83.69M $97.23M
YoY Change -13.93% -31.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001492298
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMember
CY2021Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMember
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-34950
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
SABRA HEALTH CARE REIT, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2560479
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
18500 Von Karman Avenue, Suite 550
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
CY2022Q1 dei City Area Code
CityAreaCode
888
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
393-8248
CY2022Q1 dei Security12b Title
Security12bTitle
Common stock, $.01 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
SBRA
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
230954777 shares
CY2022Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
873795000 USD
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
831324000 USD
CY2022Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5156060000 USD
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5162884000 USD
CY2022Q1 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
397074000 USD
CY2021Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
399086000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
93878000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
96680000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24836000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111996000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4443000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3890000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
52877000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54063000 USD
CY2022Q1 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
155764000 USD
CY2021Q4 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
138108000 USD
CY2022Q1 us-gaap Assets
Assets
5884932000 USD
CY2021Q4 us-gaap Assets
Assets
5966707000 USD
CY2022Q1 us-gaap Secured Debt
SecuredDebt
50645000 USD
CY2021Q4 us-gaap Secured Debt
SecuredDebt
66663000 USD
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
16792000 USD
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2022Q1 us-gaap Loans Payable To Bank
LoansPayableToBank
556307000 USD
CY2021Q4 us-gaap Loans Payable To Bank
LoansPayableToBank
594246000 USD
CY2022Q1 us-gaap Unsecured Debt
UnsecuredDebt
1733786000 USD
CY2021Q4 us-gaap Unsecured Debt
UnsecuredDebt
1733566000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
118296000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
142989000 USD
CY2022Q1 us-gaap Below Market Lease Net
BelowMarketLeaseNet
47583000 USD
CY2021Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
49713000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
2523409000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
2587177000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
230954777 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
230954777 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
230398655 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
230398655 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2310000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2304000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4481634000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4482451000 USD
CY2022Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1124095000 USD
CY2021Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1095204000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1674000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10021000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3361523000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3379530000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5884932000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5966707000 USD
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
109886000 USD
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
113383000 USD
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
10992000 USD
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
2941000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42227000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36041000 USD
CY2022Q1 us-gaap Revenues
Revenues
163105000 USD
CY2021Q1 us-gaap Revenues
Revenues
152365000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45256000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44375000 USD
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
24972000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
24443000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10396000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8938000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
475000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2025000 USD
CY2022Q1 sbra Operating And Interest Expense
OperatingAndInterestExpense
119214000 USD
CY2021Q1 sbra Operating And Interest Expense
OperatingAndInterestExpense
113861000 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-271000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-793000 USD
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
68000 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
133000 USD
CY2022Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1313000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-203000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
653000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
43688000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
33447000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
39157000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2022Q1 sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-2802000 USD
CY2021Q1 sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-5010000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
284000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
40602000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
33447000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230859993 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211450699 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231564970 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212624305 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
40602000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-251000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-644000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3379530000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2835000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
88124000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
12339000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
33789000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11695000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
33538000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52297000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
66985000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3409228000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
33447000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
33538000 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
63768000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3503404000 USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-3484000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68531000 USD
CY2022Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
20573000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
40602000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11695000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2673000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
69493000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3361523000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
40602000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
33447000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45256000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44375000 USD
CY2022Q1 sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-4474000 USD
CY2021Q1 sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-5713000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
547000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
412000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2698000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1896000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2456000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2288000 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-271000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-793000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
475000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2025000 USD
CY2022Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1313000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2802000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5010000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5457000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2873000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-20968000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10992000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63114000 USD
CY2022Q1 sbra Payments For Escrow Deposits For Potential Investments
PaymentsForEscrowDepositsForPotentialInvestments
3217000 USD
CY2021Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
28654000 USD
CY2022Q1 sbra Payments For Preferred Equity Investments
PaymentsForPreferredEquityInvestments
4074000 USD
CY2021Q1 sbra Payments For Preferred Equity Investments
PaymentsForPreferredEquityInvestments
0 USD
CY2022Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
10803000 USD
CY2021Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
10833000 USD
CY2021Q1 sbra Payments For Escrow Deposits For Potential Investments
PaymentsForEscrowDepositsForPotentialInvestments
0 USD
CY2022Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
696000 USD
CY2021Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
628000 USD
CY2022Q1 sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-729000 USD
CY2021Q1 sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-301000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2021Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
3202000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37242000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35356000 USD
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
16577000 USD
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2022Q1 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
40000000 USD
CY2021Q1 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
93000000 USD
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
16067000 USD
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
709000 USD
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
6000 USD
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2022Q1 sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
-3748000 USD
CY2021Q1 sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
87654000 USD
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
69275000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
63221000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-112519000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-69276000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-86647000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-36101000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115886000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65523000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29279000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29487000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
18383000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
21620000 USD
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
5623000 USD
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0 USD
sbra Temporary Rent Deferrals Pandemic Related Number Of Tenants
TemporaryRentDeferralsPandemicRelatedNumberOfTenants
6 tenant
sbra Temporary Rent Deferrals Pandemic Related Amount
TemporaryRentDeferralsPandemicRelatedAmount
3200000 USD
sbra Receipt Of Payment Temporary Rent Deferrals Pandemic Related Amount
ReceiptOfPaymentTemporaryRentDeferralsPandemicRelatedAmount
500000 USD
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
831324000 USD
CY2022Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5156060000 USD
CY2022Q1 sbra Real Estate Investments Joint Ventures Number
RealEstateInvestmentsJointVenturesNumber
0 investment
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
CY2022Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6029855000 USD
CY2022Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
873795000 USD
CY2022Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5156060000 USD
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5994208000 USD
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
831324000 USD
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5162884000 USD
CY2022Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5175057000 USD
CY2021Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5145096000 USD
CY2022Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
265312000 USD
CY2021Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
262969000 USD
CY2022Q1 us-gaap Land Improvements
LandImprovements
4003000 USD
CY2021Q4 us-gaap Land Improvements
LandImprovements
4295000 USD
CY2022Q1 us-gaap Land
Land
585483000 USD
CY2021Q4 us-gaap Land
Land
581848000 USD
CY2022Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6029855000 USD
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5994208000 USD
CY2022Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
873795000 USD
CY2022Q1 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
16700000 USD
CY2021Q4 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
16800000 USD
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5162884000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2022Q1 us-gaap Security Deposit Liability
SecurityDepositLiability
11200000 USD
CY2021Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
28600000 USD
CY2022Q1 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
82000000 USD
CY2021Q4 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
63000000 USD
CY2022Q1 us-gaap Variable Lease Income
VariableLeaseIncome
5100000 USD
CY2021Q1 us-gaap Variable Lease Income
VariableLeaseIncome
4800000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
305189000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
394427000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
394817000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
387304000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
370067000 USD
CY2022Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
407497000 USD
CY2022Q1 sbra Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
1410722000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
3262526000 USD
CY2021Q1 sbra Disposal Group Including Discontinued Operations Number Of Properties
DisposalGroupIncludingDiscontinuedOperationsNumberOfProperties
2 facility
CY2021Q1 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
5300000 USD
CY2021Q1 sbra Disposal Group Including Discontinued Operation Assets And Liabilities Net
DisposalGroupIncludingDiscontinuedOperationAssetsAndLiabilitiesNet
5000000.0 USD
CY2021Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
300000 USD
CY2021Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
300000 USD
CY2022Q1 sbra Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
16 loan
CY2022Q1 sbra Number Of Investments
NumberOfInvestments
23 investment
CY2022Q1 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
351463000 USD
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
347675000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
348375000 USD
CY2022Q1 sbra Financing Receivable Fixed Interest Rate
FinancingReceivableFixedInterestRate
0.076
CY2022Q1 sbra Financing Receivable Effective Interest Rate
FinancingReceivableEffectiveInterestRate
0.075
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6851000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6344000 USD
CY2022Q1 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
351463000 USD
CY2022Q1 us-gaap Notes Receivable Net
NotesReceivableNet
340824000 USD
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
342031000 USD
CY2022Q1 sbra Preferred Equity Investments Number
PreferredEquityInvestmentsNumber
7 preferredEquityInvestment
CY2022Q1 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
56034000 USD
CY2022Q1 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
56250000 USD
CY2021Q4 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
57055000 USD
CY2022Q1 sbra Preferred Equity Investment Weighted Average Contractual Rate
PreferredEquityInvestmentWeightedAverageContractualRate
0.110
CY2022Q1 sbra Preferred Equity Investment Weighted Average Effective Rate
PreferredEquityInvestmentWeightedAverageEffectiveRate
0.109
CY2022Q1 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
397074000 USD
CY2021Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
399086000 USD
CY2022Q1 sbra Investments Weighted Average Contractual Rate
InvestmentsWeightedAverageContractualRate
0.080
CY2022Q1 sbra Investments Weighted Average Effective Rate
InvestmentsWeightedAverageEffectiveRate
0.080
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
500000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1900000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6900000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6300000 USD
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
25000000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
24400000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2700000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1900000 USD
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
25400000 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
21500000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1449000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
18771000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
561984000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2089000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
502147000 USD
CY2022Q1 sbra Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1291874000 USD
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2378314000 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3043000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
17741000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
2357530000 USD
CY2022Q1 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
7153000 USD
CY2021Q1 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
28868000 USD
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
9409000 USD
CY2022Q1 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2022Q1 us-gaap Derivative Assets
DerivativeAssets
9409000 USD
CY2022Q1 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
0 USD
CY2022Q1 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
9409000 USD
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
0 USD
CY2022Q1 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
0 USD
CY2022Q1 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
0 USD
CY2022Q1 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
0 USD
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
3330000 USD
CY2021Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
3330000 USD
CY2021Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
930000 USD
CY2021Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
2400000 USD
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
3726000 USD
CY2021Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
3726000 USD
CY2021Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
930000 USD
CY2021Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
2796000 USD
CY2022Q1 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
351463000 USD
CY2021Q4 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
352159000 USD
CY2022Q1 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
56034000 USD
CY2021Q4 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
56805000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3300000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1900000 USD
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
40602000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
33447000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230859993 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211450699 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
704977 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1141455 shares
CY2022Q1 sbra Incremental Common Shares Attributable To Forward Equity Sale Agreements
IncrementalCommonSharesAttributableToForwardEquitySaleAgreements
0 shares
CY2021Q1 sbra Incremental Common Shares Attributable To Forward Equity Sale Agreements
IncrementalCommonSharesAttributableToForwardEquitySaleAgreements
32151 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231564970 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212624305 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16

Files In Submission

Name View Source Status
0001492298-22-000020-index-headers.html Edgar Link pending
0001492298-22-000020-index.html Edgar Link pending
0001492298-22-000020.txt Edgar Link pending
0001492298-22-000020-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbra-20220331.htm Edgar Link pending
sbra-20220331.xsd Edgar Link pending
sbra-20220331_cal.xml Edgar Link unprocessable
sbra-20220331_def.xml Edgar Link unprocessable
sbra-20220331_htm.xml Edgar Link completed
sbra-20220331_lab.xml Edgar Link unprocessable
sbra-20220331_pre.xml Edgar Link unprocessable
sbraex3112022q1.htm Edgar Link pending
sbraex3122022q1.htm Edgar Link pending
sbraex3212022q1.htm Edgar Link pending
sbraex3222022q1.htm Edgar Link pending
Show.js Edgar Link pending